ASX/PAB (ASX/PAB)

Australian Securities Exchange: ASX/PAB · AUD

A$0.02

-0.00 (-4.0%)· Recorded snapshot

Market cap	14M
Revenue (ttm)	9K
Net income (ttm)	-3.4M
EPS (ttm)	-A$0.01
Shares out	582.2M
Volume	1,707
Beta	1.27

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 9K
Net income (ttm): -3.4M
EPS (ttm): -A$0.01
Market cap: 14M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 14.6P50 21P75 31.9

Trailing P/En/a

P25 15.4P50 29.4P75 64.4

ROE-68.2

P25 -108P50 -50.6P75 1.1

ROIC-42.7

P25 -64.5P50 -33.5P75 0.8

Benchmarks · 1M

All ASX/PAB indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

AUD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-26
Employees	10
Enterprise value	AUD 10.6M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2006
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU000000PAB9
Last earnings date	2026-02-22
Last refreshed	2026-10-30
Last stock split date	2025-10-13
Last stock split type	Reverse
Market cap	AUD 14M
Next earnings date	2026-11-26
Price	AUD 0.02
Price currency	AUD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	asx/PAB
Website	https://patrys.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-34.58%
FCF / EV yield	-19.42%
FCF yield	-14.94%
Industry forward P/E	28.82x
P/B ratio	1.57x
P/S ratio	1,620.01x
Price / tangible book value	5.58x
Sector forward P/E	34.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Operating margin	-38,012.63%
Pretax margin	-38,012.63%
Profit per employee	AUD -341,544
Revenue per employee	AUD 899
ROA	-35.77%
ROA (5Y)	-40.73%
ROCE	-36.82%
ROE	-68.25%
ROE (5Y)	-80.65%
ROIC	-42.65%
SBC / revenue	2,671.12%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	-98.92%
Gross profit growth (Q)	-93.18%
Gross profit growth 3Y	-85.34%
Gross profit growth 5Y	-63.24%
Net income growth quarters	1
Net income growth years	0
Revenue growth	-98.92%
Revenue growth (Q)	-93.18%
Revenue growth (QoQ)	190.82%
Revenue growth 10Y	-36.68%
Revenue growth 3Y	-85.34%
Revenue growth 5Y	-63.24%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -3,853
Depreciation and amortization	AUD 346
EBIT	AUD -3.4M
EBITDA	AUD -3.4M
EPS	AUD -0.01
FCF per share	AUD -0.00
Financing cash flow	AUD 4.8M
Free cash flow	AUD -2.2M
Free cash flow minus SBC	AUD -2.4M
Gross profit	AUD 8,985
Investing cash flow	AUD -3,853
Net cash flow	AUD 2.6M
Net income	AUD -3.4M
Operating cash flow minus SBC	AUD -2.4M
Operating income	AUD -3.4M
Revenue	AUD 8,985
Stock-based compensation	AUD 240,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-3.83
Book value per share	AUD 0.01
Debt / equity	0
Goodwill	AUD 32,000
Long-term assets	AUD 6.7M
Long-term liabilities	AUD 0
Net cash (debt)	AUD 3.4M
Net cash / market cap	23.08%
Net cash growth	352.58%
Net debt / equity	-0.36
Piotroski F-Score	2
Property, plant and equipment	AUD 3,508
Shareholders' equity	AUD 9.3M
Tangible book value	AUD 2.6M
Tangible book value per share	AUD 0.00
Total assets	AUD 10.2M
Total cash	AUD 3.4M
Total debt	AUD 0
Total liabilities	AUD 918,552
WACC	11.21%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0
Current assets	AUD 3.5M
Current liabilities	AUD 918,552
Current ratio	3.84
Net working capital	AUD -755,466
Quick ratio	3.77
Working capital	AUD 2.6M
Working capital turnover	0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-200.29%
Shareholder yield	-200.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-75%
10Y return CAGR	-10.4%
10Y total return	-66.66%
150-day SMA	AUD 0.03
15Y price change	-96.55%
15Y return CAGR	-18.15%
15Y total return	-95.04%
1D price change	-4%
1M price change	-20%
1M total return	-20%
1W price change	-14.29%
1W total return	-14.29%
1Y price change	-40%
1Y return CAGR	-40.02%
1Y total return	-40%
20-day SMA	AUD 0.03
200-day SMA	AUD 0.03
3M price change	-40%
3M total return	-40%
3Y price change	-75%
3Y return CAGR	-31.72%
3Y total return	-68.18%
50-day SMA	AUD 0.03
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 0.05
52-week high date	2026-06-16
52-week low	AUD 0.02
52-week low date	2026-10-29
5Y price change	-95.24%
5Y return CAGR	-42.87%
5Y total return	-93.91%
6M price change	-20%
6M total return	-20%
All-time high	AUD 8.40
All-time high date	2007-07-13
All-time low	AUD 0.01
All-time low date	2025-04-03
Average true range (ATR)	AUD 0.00
Average volume	357.3K
Beta (1Y)	0.36
Beta (2Y)	0.78
Beta (5Y)	1.27
Change from 52-week high	-53.85%
Change from 52-week low	0%
Change from all-time high	-99.71%
Change from all-time low	100%
Change from open	0%
Day's gap	-4%
Dollar volume	AUD 40.97
High price	AUD 0.02
Low price	AUD 0.02
Monthly RSI	39.12
Open price	AUD 0.02
Previous close	AUD 0.03
Price vs 150-day SMA	-28.78%
Price vs 20-day SMA	-16.96%
Price vs 200-day SMA	-28.36%
Price vs 50-day SMA	-21.82%
Relative volume	0
RSI	31.27
Sharpe ratio	0.33
Sharpe ratio (3Y)	0.7
Sharpe ratio (5Y)	0.49
Sortino ratio	0.63
Sortino ratio (3Y)	1.25
Sortino ratio (5Y)	0.88
Volume	1.7K
Weekly RSI	37.45
YTD price change	-14.29%
YTD total return	-14.29%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	329.1M
Shares change (QoQ)	106.96%
Shares change (YoY)	200.29%
Shares held by insiders	19.5%
Shares outstanding	582.2M

Deeper analysis on ASX/PAB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/PAB report

Is a complete ASX/PAB research report available?

No complete published report is available for asx/PAB (ASX/PAB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/PAB (ASX/PAB)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/PAB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/PAB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/PAB

Frequently asked questions